Acquisition of shares of associate company

Ref: No. ABCL/SD/MUM/2026-27/JULY/57 21 July 2026 BSE Limited National Stock Exchange of India Ltd Phiroze Jeejeebhoy Towers, th Exchange Plaza, 5 Floor, Dalal Street, Plot. C/1, Mumbai 400 001 G-Block, Bandra-Kurla Complex, Bandra (East), Scrip Code: 540691 Mumbai 400 051 Scrip ID: ABCAPITAL Symbol: ABCAPITAL Dear Sir/ Madam, Sub: Intimation pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“SEBI Listing Regulations”) Pursuant to Clause 1 of Para A of Part A of Schedule III read with sub-Clause (c) of Clause (i) of sub-Regulation (4) of Regulation 30 of SEBI Listing Regulations, we wish to inform you that, Aditya Birla Capital Limited (“the Company” or “ABCL”) has made an investment of Rs. 1,23,89,43,300/- (Rupees One Hundred Twenty-Three Crore, Eighty-Nine Lakh, Forty-Three Thousand and Three Hundred Only) on rights basis, in the equity shares of Aditya Birla Health Insurance Co. Limited (“ABHI”). Pursuant to the aforesaid investments, there is no change in the percentage shareholding of ABCL and ABHI continues to be an associate of the Company. Further details as required under Regulation 30 of the SEBI Listing Regulations, read with SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated 30 January 2026, are enclosed as Annexure. We request you to take the aforesaid on records. Thanking you, Yours sincerely, For Aditya Birla Capital Limited Santosh Haldankar Company Secretary & Compliance Officer Encl.: As above Luxembourg Stock Exchange Citi Bank N.A. Market & Surveillance Dept., Custodial Services P.O. Box 165, L-2011 Luxembourg, FIFC, 11th Floor, C-54 & 55, G Block Grand Duchy of Luxembourg Bandra Kurla Complex Bandra (East), Mumbai 400 051 Citi Bank N.A. Listing Agent Depositary Receipt Services Banque Internationale à Luxembourg SA 388 Greenwich Street 69 route d'Esch 14th Floor, New York, L - 2953 Luxembourg NY 10013 Grand Duchy of Luxembourg Annexure Details required to be disclosed under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 - Continuous Disclosure Requirements for Listed Entities Particulars Remarks a) Name of the target entity, Aditya Birla Health Insurance Co. Limited (“ABHI”), is an details in brief such as size, existing associate of the Company. turnover etc. b) Whether the acquisition would ABHI being an associate, is a related party of the Company. fall within related party The transaction is at “arm’s length”. transaction(s) and whether the promoter/ promoter group/ group companies have any interest in the entity being acquired? If yes, nature of interest and details thereof and whether the same is done at “ arm’s length” c) Industry to which the entity Health Insurance being acquired belongs d) Objects and impact of ABCL is making the investment in ABHI to meet its solvency acquisition (including but not margin. limited to, disclosure of reasons for acquisition of target entity, if its business is outside the main line of business of the listed entity) e) Brief details of any Not applicable governmental or regulatory approvals required for the a cquisition. f) Indicative time period for ABHI has allotted the equity shares on 21 July 2026 completion of the acquisition g) Consideration - whether cash Cash consideration or share swap or any other form and details of the same h) Cost of acquisition and/or the Subscription of equity shares of ABHI, on rights basis for price at which the shares are aggregate cash consideration of Rs. 1,23,89,43,300/- acquired. (Rupees One Hundred Twenty-Three Crore, Eighty-Nine Lakh, Forty-Three Thousand and Three Hundred Only i) Percentage of shareholding / Percentage shareholding of ABCL in ABHI continues to control acquired and / or remain at 45.89%. number of shares acquired. j) Brief background about the The investment is made on rights basis in ABHI, which is an entity acquired in terms of existing associate of ABCL. products/line of business acquired, date of incorporation, history of last 3 years turnover, country in which the acquired entity has presence and any other significant information (in brief)